✦ LIBER ✦

Benefits and risks around glycaemic control in diabetes: where are we now?

✍ Scribed by J. Reckless; A. Robinson

Book ID: 111309304
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 135 KB
Volume: 64
Category: Article
ISSN: 1368-5031
DOI: 10.1111/j.1742-1241.2010.02368.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intensive glycaemic control in type 2 di

Intensive glycaemic control in type 2 diabetes: where are we now?

✍ Stuart Lee; John Harvey 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 66 KB

Yellow fever control in Cameroon: Where

Yellow fever control in Cameroon: Where are we now and where are we going?

✍ Charles Shey Wiysonge; Emmanuel Nomo; Jeanne Mawo; James Ofal; Julienne Mimbouga 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 347 KB

Two decades of the public health approac

Two decades of the public health approach to skin cancer control in Australia: Why, how and where are we now?

✍ Robin Marks 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

Incidence and mortality rates due to skin cancer are rising in most Western countries. Early detection of these tumours at a stage when they can be easily cured is the primary approach taken by many people wishing to deal with the problem. A primary prevention approach, that is, reduction in sunligh

Glycaemic control and control of risk fa

Glycaemic control and control of risk factors in diabetes patients in an ophthalmology clinic: what lessons have we learned from the UKPDS and DCCT studies?

✍ Higgins, Gareth T. ;Khan, Javeed ;Pearce, Ian A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB